ETF PROAI

IBBQvsSPMD

Invesco Nasdaq Biotechnology ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IBBQ 137SPMD 112Oct 25Oct 26GROWTH OF $100
Head to head
IBBQSPMD
Expense ratio0.19%0.030%
Assets$106M$17.9B
Net flow, 1 month+$12M+$207M
Net flow, 1 year+$48M+$2.1B
Return, YTD+21.0%+11.0%
Return, 1 year+37.0%+11.9%
Avg daily volume40K1.6M
Holdings219401
ListedJun 11, 2021Nov 8, 2005
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

THE DESK BRIEF

Flows, fee cuts, and closure risk on the funds you watch — every trading morning.